Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
How Drug Repurposing Is Revitalizing the Pharma Industry
Posted on October 16th, 2018 by Christy J. Wilson in Pharma R&D
The average expense of bringing a new drug to market has increased by more than 200 percent since the 1990s, with development costs regularly running into the billions. As pharma revenues continue to sink below the costs of creating commercially viable drugs, a growing number of developers are exploring a different approach: seeking out additional monetizable uses for drugs to which they already own intellectual property rights. Continue reading “How Drug Repurposing Is Revitalizing the Pharma Industry” »
AI Can Work Wonders, But Can It Create Miracle Cures?
Posted on June 19th, 2018 by Christy J. Wilson in Pharma R&D
Modern technology seems downright magical at times. There are so many things that it can do for us at the push of a button, whether it’s our personal devices instantly retrieving information or massive industrial machines Continue reading “AI Can Work Wonders, But Can It Create Miracle Cures?” »
When Looking to Accelerate the Pace of Research, Having the Right Multidisciplinary Tools Matters
Posted on May 18th, 2018 by Christy J. Wilson in Pharma R&D
Have you ever heard the term “stay in your lane”? While it may be applicable in some workplaces, where people are expected to keep their focus narrow, these days it isn’t something you’ll hear much in pharmaceutical-related industries. Continue reading “When Looking to Accelerate the Pace of Research, Having the Right Multidisciplinary Tools Matters” »
Pharma’s Path to Adopting AI and Other Emerging Technologies
Posted on February 7th, 2018 by Christy J. Wilson in Pharma R&D
Right now in the pharmaceutical space, emerging technologies are dominating the conversation. As the cost of drug development soars, and the potential for success seems more and more elusive, the industry is pinning its hopes on promising technological breakthroughs. Continue reading “Pharma’s Path to Adopting AI and Other Emerging Technologies” »
